Skip to main content

Arteriovenous Fistula

1
Pipeline Programs
6
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
1 program
1
Angioplasty of all peripheral AVF stenosisPhase 31 trial
Active Trials
NCT06553443Recruiting94Est. Dec 2029
Medtronic
MedtronicNJ - Phillipsburg
2 programs
IN.PACT™ AV Drug Coated BalloonN/A1 trial
ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous FistulaeN/A1 trial
Active Trials
NCT04543539Active Not Recruiting240Est. Feb 2029
NCT02180945Completed110Est. May 2016
Bilim Pharmaceuticals
Bilim PharmaceuticalsTurkey - Istanbul
1 program
Arteriovenous Fistula Cannulation Practices and Dialysis AdequacyN/A1 trial
Active Trials
NCT04270292Completed164Est. Jan 2020
Sonavex
SonavexMD - Baltimore
1 program
EchoMark/EchoSureN/A1 trial
Active Trials
NCT04017910Terminated17Est. May 2021
Coordination Pharmaceuticals
1 program
Valsalva ManeuverN/A1 trial
Active Trials
NCT07066579Not Yet Recruiting60Est. Sep 2026
Venova Medical
Venova MedicalCA - Los Gatos
1 program
Velocity pAVF systemN/A1 trial
Active Trials
NCT05757726Completed10Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Boston ScientificAngioplasty of all peripheral AVF stenosis
Coordination PharmaceuticalsValsalva Maneuver
Venova MedicalVelocity pAVF system
MedtronicIN.PACT™ AV Drug Coated Balloon
SonavexEchoMark/EchoSure
Bilim PharmaceuticalsArteriovenous Fistula Cannulation Practices and Dialysis Adequacy
MedtronicONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae

Clinical Trials (7)

Total enrollment: 695 patients across 7 trials

NCT06553443Boston ScientificAngioplasty of all peripheral AVF stenosis

Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis

Start: Jan 2024Est. completion: Dec 202994 patients
Phase 3Recruiting
NCT07066579Coordination PharmaceuticalsValsalva Maneuver

Evaluating the Effect of the Valsalva Maneuver on Invasive Pain During Arteriovenous Fistula Cannulation in Hemodialysis Patients

Start: Sep 2025Est. completion: Sep 202660 patients
N/ANot Yet Recruiting
NCT05757726Venova MedicalVelocity pAVF system

Early Feasibility of the Velocity™ Percutaneous PAVF System

Start: Feb 2023Est. completion: Oct 202410 patients
N/ACompleted
NCT04543539MedtronicIN.PACT™ AV Drug Coated Balloon

IN.PACT™ AV Access Post-Approval Study (PAS002)

Start: Nov 2020Est. completion: Feb 2029240 patients
N/AActive Not Recruiting
NCT04017910SonavexEchoMark/EchoSure

Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients

Start: Dec 2019Est. completion: May 202117 patients
N/ATerminated
NCT04270292Bilim PharmaceuticalsArteriovenous Fistula Cannulation Practices and Dialysis Adequacy

Arteriovenous Fistula Cannulation Practices and Dialysis Adequacy

Start: May 2019Est. completion: Jan 2020164 patients
N/ACompleted
NCT02180945MedtronicONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae

ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae

Start: Jul 2013Est. completion: May 2016110 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 695 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.